Quality standard
Update information
Update information
June 2016: This quality standard was updated and statements prioritised in 2011 were replaced.
Statements are marked as [new 2016] or [2011, updated 2016]:
-
[new 2016] if the statement covers a new area for quality improvement
-
[2011, updated 2016] if the statement covers an area for quality improvement included in the 2011 quality standard and has been updated.
The previous version of the quality standard for breast cancer is available as a pdf.
Minor changes since publication
May 2024: Changes have been made to align this quality standard with the new NICE diagnostics guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Statement 3 was amended to reflect recommendations on testing options for some people with ER-positive or PR-positive, HER2-negative early breast cancer with 1 to 3 positive lymph nodes. A structure measure has been removed from statement 1.
Data source sections have been updated throughout, and additional examples of data sources provided where relevant.
December 2018: Changes have been made to align this quality standard with the updated NICE diagnostics guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Statement 3 was amended to reflect the different options for tumour profiling tests now recommended in the guidance. The source guidance was also updated.
July 2018: Changes have been made to align this quality standard with the updated NICE guideline on early and locally advanced breast cancer. References and source guidance sections have been updated.
August 2017: The rationale and source guidance details for statement 4 were updated and a definition added to ensure consistency with the NICE guideline on advanced breast cancer, which was updated in August 2017.